ALMODAWAT

Almodawat Specialized Medical Hospital Company

9594StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	4.28M	10.07M	13.60M	5.09M	2.27M
Free Cash Flow	1.90M	-8.52M	9.68M	2.32M	-2.26M
Capital Expenditures	-2.38M	-18.59M	-3.92M	-2.77M	-4.53M
Investing & Financing
Investing Cash Flow	-2.41M	-18.71M	-3.92M	-2.78M	-4.53M
Financing Cash Flow	13.48M	24.14M	-10.79M	-7.69M	6.90M
Dividends Paid	-2.85M	-21.85M	-9.35M	—	—
Share Repurchase	-361.65K	—	—	—	—
Operating Activities
Operating Cash Flow	4.28M	10.07M	13.60M	5.09M	2.27M
Net Income	18.98M	6.07M	18.59M	10.31M	-2.21M
Change in Accounts Payable	3.72M	-1.01M	0.23M	-1.53M	-0.01M
Change in Accounts Receivable	-35.59M	2.55M	-16.19M	-9.43M	3.06M
Change in Inventory	-1.19M	-0.46M	-1.67M	-0.68M	1.61M
Change in Other Net Operating Assets	5.47M	-4.95M	5.05M	1.99M	-1.51M
Change in Working Capital	-27.58M	-3.87M	-12.58M	-9.65M	3.15M
Other Operating Activities	2.82M	0.63M	2.57M	1.37M	-0.59M
Depreciation & Amortization	8.23M	5.84M	3.66M	2.10M	1.92M
Other Amortization	21.92K	10.40K	5.94K	5.85K	5.35K
Cash Interest Paid	1.47M	0.72M	0.80M	0.67M	—
Miscellaneous Cash Flow Adjustments	-19.00M	—	—	—	—
Investing Activities
Investing Cash Flow	-2.41M	-18.71M	-3.92M	-2.78M	-4.53M
Capital Expenditures	-2.38M	-18.59M	-3.92M	-2.77M	-4.53M
Cash Acquisitions	-7.75K	—	—	—	—
Other Investing Activities	—	28.92K	—	—	—
Sale (Purchase) of Intangibles	-25.76K	-151.63K	—	-8.41K	-3.60K
Loss (Gain) From Sale of Assets	127.10K	-153.59K	—	—	—
Financing Activities
Financing Cash Flow	13.48M	24.14M	-10.79M	-7.69M	6.90M
Common Dividends Paid	-2.85M	-21.85M	-9.35M	—	—
Issuance of Common Stock	—	52.73M	—	—	—
Repurchase of Common Stock	-361.65K	—	—	—	—
Long-Term Debt Issued	36.09M	0.85M	2.82M	—	7.41M
Long-Term Debt Repaid	-17.93M	-6.86M	-3.46M	-7.02M	-0.52M
Net Debt Issued (Repaid)	18.17M	-6.01M	-0.65M	-7.02M	6.90M
Other Financing Activities	-1.47M	-0.72M	-0.80M	-0.67M	—
Free Cash Flow & Returns
Free Cash Flow	1.90M	-8.52M	9.68M	2.32M	-2.26M
Free Cash Flow Growth	—	—	+317.5%	—	—
Free Cash Flow Margin	+1.6%	-11.3%	+13.0%	+4.0%	-5.5%
Free Cash Flow Per Share	0.03	-0.12	0.17	0.04	—
Levered Free Cash Flow	-1.76M	-12.96M	3.91M	-1.70M	—
Unlevered Free Cash Flow	-0.50M	-12.26M	4.62M	-1.27M	—
Operating Cash Flow Growth	-57.5%	-26.0%	+167.1%	+124.2%	—
Net Cash Flow	-3.65M	15.49M	-1.12M	-5.38M	4.64M

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	4.28M	10.07M	13.60M	5.09M	2.27M
Free Cash Flow	1.90M	-8.52M	9.68M	2.32M	-2.26M
Capital Expenditures	-2.38M	-18.59M	-3.92M	-2.77M	-4.53M
Investing & Financing
Investing Cash Flow	-2.41M	-18.71M	-3.92M	-2.78M	-4.53M
Financing Cash Flow	13.48M	24.14M	-10.79M	-7.69M	6.90M
Dividends Paid	-2.85M	-21.85M	-9.35M	—	—
Share Repurchase	-361.65K	—	—	—	—
Operating Activities
Operating Cash Flow	4.28M	10.07M	13.60M	5.09M	2.27M
Net Income	18.98M	6.07M	18.59M	10.31M	-2.21M
Change in Accounts Payable	3.72M	-1.01M	0.23M	-1.53M	-0.01M
Change in Accounts Receivable	-35.59M	2.55M	-16.19M	-9.43M	3.06M
Change in Inventory	-1.19M	-0.46M	-1.67M	-0.68M	1.61M
Change in Other Net Operating Assets	5.47M	-4.95M	5.05M	1.99M	-1.51M
Change in Working Capital	-27.58M	-3.87M	-12.58M	-9.65M	3.15M
Other Operating Activities	2.82M	0.63M	2.57M	1.37M	-0.59M
Depreciation & Amortization	8.23M	5.84M	3.66M	2.10M	1.92M
Other Amortization	21.92K	10.40K	5.94K	5.85K	5.35K
Cash Interest Paid	1.47M	0.72M	0.80M	0.67M	—
Miscellaneous Cash Flow Adjustments	-19.00M	—	—	—	—
Investing Activities
Investing Cash Flow	-2.41M	-18.71M	-3.92M	-2.78M	-4.53M
Capital Expenditures	-2.38M	-18.59M	-3.92M	-2.77M	-4.53M
Cash Acquisitions	-7.75K	—	—	—	—
Other Investing Activities	—	28.92K	—	—	—
Sale (Purchase) of Intangibles	-25.76K	-151.63K	—	-8.41K	-3.60K
Loss (Gain) From Sale of Assets	127.10K	-153.59K	—	—	—
Financing Activities
Financing Cash Flow	13.48M	24.14M	-10.79M	-7.69M	6.90M
Common Dividends Paid	-2.85M	-21.85M	-9.35M	—	—
Issuance of Common Stock	—	52.73M	—	—	—
Repurchase of Common Stock	-361.65K	—	—	—	—
Long-Term Debt Issued	36.09M	0.85M	2.82M	—	7.41M
Long-Term Debt Repaid	-17.93M	-6.86M	-3.46M	-7.02M	-0.52M
Net Debt Issued (Repaid)	18.17M	-6.01M	-0.65M	-7.02M	6.90M
Other Financing Activities	-1.47M	-0.72M	-0.80M	-0.67M	—
Free Cash Flow & Returns
Free Cash Flow	1.90M	-8.52M	9.68M	2.32M	-2.26M
Free Cash Flow Growth	—	—	+317.5%	—	—
Free Cash Flow Margin	+1.6%	-11.3%	+13.0%	+4.0%	-5.5%
Free Cash Flow Per Share	0.03	-0.12	0.17	0.04	—
Levered Free Cash Flow	-1.76M	-12.96M	3.91M	-1.70M	—
Unlevered Free Cash Flow	-0.50M	-12.26M	4.62M	-1.27M	—
Operating Cash Flow Growth	-57.5%	-26.0%	+167.1%	+124.2%	—
Net Cash Flow	-3.65M	15.49M	-1.12M	-5.38M	4.64M